Total Payments
$13,372
2024 Payments
$188.34
Companies
34
Transactions
132
Medicare Patients
7,243
Medicare Billing
$1.1M
Payment Breakdown by Category
Consulting$8,709 (65.1%)
Food & Beverage$2,179 (16.3%)
Other$1,566 (11.7%)
Travel$892.73 (6.7%)
Gifts$25.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,709 | 2 | 65.1% |
| Food and Beverage | $2,179 | 111 | 16.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,551 | 15 | 11.6% |
| Travel and Lodging | $892.73 | 2 | 6.7% |
| Gift | $25.00 | 1 | 0.2% |
| Entertainment | $14.96 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HOLOGIC INC | $9,858 | 9 | $0 (2022) |
| Amgen Inc. | $1,664 | 21 | $0 (2019) |
| Smith+Nephew, Inc. | $473.47 | 39 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $209.80 | 8 | $0 (2024) |
| Carl Zeiss Meditec, Inc. | $163.92 | 4 | $0 (2021) |
| Focal Therapeutics, Inc. | $102.61 | 2 | $0 (2019) |
| MAYNE PHARMA INC. | $85.68 | 4 | $0 (2022) |
| Endomagnetics Ltd | $81.66 | 2 | $0 (2021) |
| PUMA BIOTECHNOLOGY, INC. | $78.18 | 5 | $0 (2021) |
| Tempus AI, Inc | $56.36 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $188.34 | 10 | Tempus AI, Inc ($56.36) |
| 2023 | $171.57 | 6 | Myriad Genetic Laboratories, Inc. ($81.75) |
| 2022 | $7,251 | 38 | HOLOGIC INC ($6,823) |
| 2021 | $385.74 | 17 | Smith+Nephew, Inc. ($102.14) |
| 2020 | $109.86 | 6 | Endomagnetics Ltd ($25.00) |
| 2019 | $555.87 | 12 | Amgen Inc. ($327.20) |
| 2018 | $3,290 | 23 | HOLOGIC INC ($3,035) |
| 2017 | $1,420 | 20 | Amgen Inc. ($1,256) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Pharma Products | ||||||
| 12/04/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $13.59 | General |
| 10/31/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 09/19/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Pharma Products | ||||||
| 08/22/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $17.75 | General |
| 07/11/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $25.02 | General |
| 05/09/2024 | Bard Peripheral Vascular, Inc. | PowerPort M.R.I. Implantable Port (Device) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Vascular/Oncology | ||||||
| 04/10/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: ONCOLOGY | ||||||
| 02/28/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Pharma Products | ||||||
| 11/08/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $81.75 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Pain Management | ||||||
| 09/20/2023 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 07/06/2023 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Pharma Products | ||||||
| 05/10/2023 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Extra Cellular Matrix | ||||||
| 02/22/2023 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Pharma Products | ||||||
| 12/19/2022 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Extra Cellular Matrix | ||||||
| 12/01/2022 | Becton, Dickinson and Company | — | Food and Beverage | In-kind items and services | $17.45 | General |
| 11/18/2022 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: Extra Cellular Matrix | ||||||
| 09/28/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Pharma Products | ||||||
| 09/20/2022 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: Extra Cellular Matrix | ||||||
| 09/14/2022 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 08/18/2022 | HOLOGIC INC | — | Food and Beverage | In-kind items and services | $28.69 | General |
| 07/28/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Pharma Products | ||||||
| 07/08/2022 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: Extra Cellular Matrix | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,546 | 1,657 | $1.3M | $221,476 |
| 2022 | 27 | 1,865 | 2,010 | $1.7M | $302,406 |
| 2021 | 27 | 2,000 | 2,141 | $1.8M | $324,068 |
| 2020 | 25 | 1,832 | 2,010 | $1.5M | $281,634 |
Total Patients
7,243
Total Services
7,818
Medicare Billing
$1.1M
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 19083 | Biopsy of breast and placement of locating device using ultrasound, first growth | Office | 2023 | 74 | 79 | $130,034 | $27,294 | 21.0% |
| 19301 | Partial removal of breast | Facility | 2023 | 63 | 65 | $109,778 | $22,110 | 20.1% |
| 19318 | Breast reduction | Facility | 2023 | 27 | 27 | $181,953 | $20,170 | 11.1% |
| 38525 | Biopsy or removal of deep lymph nodes of underarm | Facility | 2023 | 87 | 87 | $164,517 | $16,870 | 10.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 197 | 232 | $41,528 | $12,898 | 31.1% |
| 19303 | Simple complete removal of breast | Facility | 2023 | 16 | 16 | $44,374 | $12,740 | 28.7% |
| 14301 | Repair of wound by transferring skin, 30.1-60.0 sq cm | Facility | 2023 | 36 | 36 | $82,296 | $12,140 | 14.8% |
| 19125 | Removal of growth of breast identified by x-ray marker, first growth | Facility | 2023 | 35 | 35 | $57,610 | $11,731 | 20.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 154 | 154 | $40,795 | $11,538 | 28.3% |
| 76642 | Limited ultrasound scan of 1 breast | Office | 2023 | 152 | 185 | $41,181 | $10,405 | 25.3% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2023 | 98 | 98 | $35,378 | $9,850 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 105 | $27,825 | $9,538 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $24,131 | $7,217 | 29.9% |
| 36561 | Insertion of central venous tube with port (5 years or older) | Facility | 2023 | 31 | 31 | $117,924 | $7,033 | 6.0% |
| 19340 | Placement of implant on same day of breast reconstruction | Facility | 2023 | 14 | 14 | $61,422 | $4,751 | 7.7% |
| 19081 | Biopsy of breast and placement of locating device using x-ray with needle, first growth | Facility | 2023 | 37 | 37 | $17,723 | $4,227 | 23.8% |
| 19294 | Placement of radiation therapy device in breast for radiation therapy during surgery with partial removal of breast | Facility | 2023 | 32 | 32 | $13,696 | $3,771 | 27.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 61 | 70 | $7,420 | $2,681 | 36.1% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 28 | 28 | $9,596 | $2,423 | 25.2% |
| 36590 | Removal of central venous tube with port or pump | Facility | 2023 | 16 | 16 | $18,128 | $2,211 | 12.2% |
| 19285 | Placement of locating device in breast using ultrasound guidance, first growth | Facility | 2023 | 63 | 64 | $15,222 | $2,058 | 13.5% |
| 12035 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 12.6-20.0 cm | Facility | 2023 | 16 | 16 | $14,112 | $1,505 | 10.7% |
| 11601 | Removal of cancer skin growth of body, arms, or legs, 0.6-1.0 cm | Facility | 2023 | 16 | 18 | $11,772 | $1,177 | 10.0% |
| 12034 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | Facility | 2023 | 12 | 12 | $8,004 | $1,144 | 14.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Facility | 2023 | 17 | 18 | $13,104 | $1,102 | 8.4% |
About Dr. Phillip Ley, M.D
Dr. Phillip Ley, M.D is a Surgical Oncology healthcare provider based in Flowood, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790890499.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Phillip Ley, M.D has received a total of $13,372 in payments from pharmaceutical and medical device companies, with $188.34 received in 2024. These payments were reported across 132 transactions from 34 companies. The most common payment nature is "Consulting Fee" ($8,709).
As a Medicare-enrolled provider, Ley has provided services to 7,243 Medicare beneficiaries, totaling 7,818 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgical Oncology
- Location Flowood, MS
- Active Since 08/20/2006
- Last Updated 08/19/2020
- Taxonomy Code 2086X0206X
- Entity Type Individual
- NPI Number 1790890499
Products in Payments
- VIERA (Device) $2,040
- IMLYGIC (Biological) $1,551
- COLLAGENASE SANTYL (Drug) $194.34
- IORT (Device) $163.92
- MYRISK (Device) $119.90
- myRisk (Device) $89.90
- GRAFIX PL (Medical Supply) $78.13
- STRAVIX (Medical Supply) $77.07
- STRAVIX PL (Medical Supply) $69.05
- Ultrasound (Device) $63.92
- BioZorb (Device) $63.41
- Magseed (Device) $56.66
- INNOVAMATRIX AC (Device) $53.01
- Nerlynx (Drug) $52.55
- SPY-PHI SYSTEM (Device) $49.45
- Prolia (Biological) $45.06
- Savi SCOUT (Device) $39.27
- Biozorb (Device) $39.20
- Viera (Device) $38.37
- Herceptin (Biological) $36.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.